vs

Side-by-side financial comparison of BayFirst Financial Corp. (BAFN) and CRYO CELL INTERNATIONAL INC (CCEL). Click either name above to swap in a different company.

BayFirst Financial Corp. is the larger business by last-quarter revenue ($10.3M vs $7.8M, roughly 1.3× CRYO CELL INTERNATIONAL INC). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -55.0%, a 6.3% gap on every dollar of revenue. Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -29.6%).

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

BAFN vs CCEL — Head-to-Head

Bigger by revenue
BAFN
BAFN
1.3× larger
BAFN
$10.3M
$7.8M
CCEL
Higher net margin
CCEL
CCEL
6.3% more per $
CCEL
-48.7%
-55.0%
BAFN
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-29.6%
BAFN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BAFN
BAFN
CCEL
CCEL
Revenue
$10.3M
$7.8M
Net Profit
$-5.7M
$-3.8M
Gross Margin
77.9%
Operating Margin
-50.6%
Net Margin
-55.0%
-48.7%
Revenue YoY
-2.3%
Net Profit YoY
-130.6%
-105.1%
EPS (diluted)
$-1.48
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAFN
BAFN
CCEL
CCEL
Q1 26
$10.3M
Q4 25
$11.2M
$7.8M
Q3 25
$10.2M
$7.8M
Q2 25
$23.1M
$7.9M
Q1 25
$19.8M
$8.0M
Q4 24
$32.9M
$8.0M
Q3 24
$21.7M
$8.1M
Q2 24
$20.8M
$8.0M
Net Profit
BAFN
BAFN
CCEL
CCEL
Q1 26
$-5.7M
Q4 25
$-2.5M
$-3.8M
Q3 25
$-18.9M
$749.4K
Q2 25
$-1.2M
$355.8K
Q1 25
$-335.0K
$282.9K
Q4 24
$9.8M
$-1.9M
Q3 24
$1.1M
$1.1M
Q2 24
$866.0K
$655.8K
Gross Margin
BAFN
BAFN
CCEL
CCEL
Q1 26
Q4 25
77.9%
Q3 25
77.0%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Operating Margin
BAFN
BAFN
CCEL
CCEL
Q1 26
Q4 25
-25.3%
-50.6%
Q3 25
-253.0%
24.3%
Q2 25
-7.1%
18.8%
Q1 25
-2.3%
13.3%
Q4 24
-1.5%
Q3 24
7.1%
17.2%
Q2 24
5.9%
17.3%
Net Margin
BAFN
BAFN
CCEL
CCEL
Q1 26
-55.0%
Q4 25
-22.1%
-48.7%
Q3 25
-184.7%
9.6%
Q2 25
-5.3%
4.5%
Q1 25
-1.7%
3.5%
Q4 24
91.8%
-23.2%
Q3 24
5.2%
13.0%
Q2 24
4.2%
8.2%
EPS (diluted)
BAFN
BAFN
CCEL
CCEL
Q1 26
$-1.48
Q4 25
$-0.71
$-0.46
Q3 25
$-4.66
$0.09
Q2 25
$-0.39
$0.04
Q1 25
$-0.17
$0.03
Q4 24
$2.21
$-0.23
Q3 24
$0.18
$0.13
Q2 24
$0.12
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAFN
BAFN
CCEL
CCEL
Cash + ST InvestmentsLiquidity on hand
$134.5M
$3.3M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$81.9M
$-18.6M
Total Assets
$1.2B
$61.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAFN
BAFN
CCEL
CCEL
Q1 26
$134.5M
Q4 25
$207.0M
$3.3M
Q3 25
$118.5M
$3.2M
Q2 25
$77.3M
$4.4M
Q1 25
$63.2M
$3.5M
Q4 24
$77.8M
$3.5M
Q3 24
$64.4M
$2.1M
Q2 24
$60.8M
$1.5M
Total Debt
BAFN
BAFN
CCEL
CCEL
Q1 26
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Stockholders' Equity
BAFN
BAFN
CCEL
CCEL
Q1 26
$81.9M
Q4 25
$87.6M
$-18.6M
Q3 25
$89.7M
$-14.8M
Q2 25
$108.2M
$-15.6M
Q1 25
$110.1M
$-14.7M
Q4 24
$110.9M
$-13.2M
Q3 24
$102.3M
$-9.6M
Q2 24
$101.0M
$-10.7M
Total Assets
BAFN
BAFN
CCEL
CCEL
Q1 26
$1.2B
Q4 25
$1.3B
$61.7M
Q3 25
$1.3B
$63.2M
Q2 25
$1.3B
$64.4M
Q1 25
$1.3B
$64.4M
Q4 24
$1.3B
$64.7M
Q3 24
$1.2B
$62.9M
Q2 24
$1.2B
$62.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAFN
BAFN
CCEL
CCEL
Operating Cash FlowLast quarter
$1.3M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAFN
BAFN
CCEL
CCEL
Q1 26
Q4 25
$285.3M
$1.3M
Q3 25
$47.3M
$2.5M
Q2 25
$63.3M
$707.0K
Q1 25
$74.2M
$954.1K
Q4 24
$390.5M
$2.2M
Q3 24
$90.8M
$2.4M
Q2 24
$78.8M
$1.8M
Free Cash Flow
BAFN
BAFN
CCEL
CCEL
Q1 26
Q4 25
$285.0M
$1.2M
Q3 25
$47.3M
$2.5M
Q2 25
$63.1M
$644.6K
Q1 25
$74.1M
$892.0K
Q4 24
$388.8M
$2.1M
Q3 24
$90.5M
$2.3M
Q2 24
$78.4M
$21.5K
FCF Margin
BAFN
BAFN
CCEL
CCEL
Q1 26
Q4 25
2554.2%
15.5%
Q3 25
462.2%
31.9%
Q2 25
272.7%
8.1%
Q1 25
375.1%
11.2%
Q4 24
1180.9%
26.8%
Q3 24
416.5%
27.9%
Q2 24
376.1%
0.3%
Capex Intensity
BAFN
BAFN
CCEL
CCEL
Q1 26
Q4 25
2.7%
0.9%
Q3 25
0.1%
0.5%
Q2 25
0.8%
0.8%
Q1 25
0.4%
0.8%
Q4 24
5.1%
0.1%
Q3 24
1.5%
2.3%
Q2 24
1.9%
21.8%
Cash Conversion
BAFN
BAFN
CCEL
CCEL
Q1 26
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
39.95×
Q3 24
79.85×
2.32×
Q2 24
90.94×
2.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAFN
BAFN

Net Interest Income$9.4M91%
Noninterest Income$884.0K9%

CCEL
CCEL

Segment breakdown not available.

Related Comparisons